Vagal Nerve Stimulation for Post-COVID Fatigue

Overview

About this study

The purpose of this study is to evaluate the impact of vagal nerve stimulation on symptom burden, neuroinflammatory change, and blood markers of inflammation in patients with post COVID syndrome who have fatigue and headache.

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inclusion Criteria:

  • Age ≥ 18 years old.
  • Presence of fatigue and post exertional malaise.
  • Presence of headache
  • Clinical diagnosis of post COVID syndrome.
  • They have consented to participate in the study
  • They have the ability to participate in all aspects of the study.

Exclusion Criteria: 

  • Age < 18 years old.
  • Pregnant.
  • Prior adverse reaction to 14FDG.
  • Active implantable medical device e.g. pacemaker, hearing aid implant
  • Metallic device e.g. stent, orthopedic hardware in neck
  • Using another electronic device at the same time e.g. TENS, mobile phone. 
  • Any other condition deemed exclusionary by the study principal investigator

Eligibility last updated 1/26/22. Questions regarding updates should be directed to the study team contact.

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location Status Contact

Rochester, Minn.

Mayo Clinic principal investigator

Ryan Hurt, M.D., Ph.D.

Closed for enrollment

Contact information:

Jennifer Hanson

(507) 255-6205

Hanson.Jennifer6@mayo.edu

More information

Publications

Publications are currently not available
.
CLS-20535562

Mayo Clinic Footer